Molecular testing of thyroid fine-needle aspirations improves presurgical diagnosis and supports the histologic identification of minimally invasive follicular thyroid carcinomas

Thyroid

Volumn 25, Issue 4, 2015, Pages 401-409

  Eszlinger, Markus ^a   Piana, Simonetta ^b   Moll, Anja ^a   Bösenberg, Eileen ^a   Bisagni, Alessandra ^b   Ciarrocchi, Alessia ^b   Ragazzi, Moira ^b   Paschke, Ralf ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b S MARIA NUOVA HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; TUMOR MARKER;

ARTICLE; CANCER PATIENT; CANCER SURGERY; COMPARATIVE STUDY; CYTOLOGY; DIFFERENTIATED THYROID CANCER; DNA EXTRACTION; DNA SYNTHESIS; FINE NEEDLE ASPIRATION BIOPSY; GENE MUTATION; HIGH RESOLUTION MELTING ANALYSIS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MOLECULAR DIAGNOSIS; ONCOCYTOMA; POINT MUTATION; POORLY DIFFERENTIATED THYROID CANCER; PREVALENCE; PRIORITY JOURNAL; PYROSEQUENCING; REAL TIME POLYMERASE CHAIN REACTION; RISK FACTOR; RNA EXTRACTION; THYROID FOLLICULAR CARCINOMA; THYROID NODULE; ADENOCARCINOMA, FOLLICULAR; GENE REARRANGEMENT; GENETICS; MUTATION; NUCLEOTIDE SEQUENCE; PATHOLOGY; PREDICTIVE VALUE; RETROSPECTIVE STUDY; TUMOR INVASION;

ADENOCARCINOMA, FOLLICULAR; BIOMARKERS, TUMOR; BIOPSY, FINE-NEEDLE; DNA MUTATIONAL ANALYSIS; GENE REARRANGEMENT; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; MUTATION; NEOPLASM INVASIVENESS; PREDICTIVE VALUE OF TESTS; REAL-TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84926466422     PISSN: 10507256     EISSN: 15579077     Source Type: Journal    
DOI: 10.1089/thy.2014.0362     Document Type: Article

References (29)

1. British Thyroid Association, Royal College of Physicians 2007 Guidelines for the Management of Thyroid Cancer. Second edition. Report of the Thyroid Cancer Guidelines Update Group. Royal College of Physicians, London.
2. Gharib H, Papini E, Paschke R, Duick DS, Valcavi R, Hegedus L, Vitti P 2010 American Association of Clinical Endocrinologists, Italian Association of Clinical Endocrinologists and European Thyroid Association Medical Guidelines For Clinical Practice For the Diagnosis and Management of Thyroid Nodules. Endocr Pract 16:1-43.
3. Eszlinger M, Paschke R 2010 Molecular fine-needle aspiration biopsy diagnosis of thyroid nodules by tumor specific mutations and gene expression patterns. Mol Cell Endocrinol 322:29-37.
4. Hegedus L 2004 Clinical practice. The thyroid nodule. N Engl J Med 351:1764-1771.
5. Paschke R, Hegedus L, Alexander E, Valcavi R, Papini E, Gharib H 2011 Thyroid nodule guidelines: agreement, disagreement and need for future research. Nat Rev Endocrinol 7:354-361.
6. Camargo R, Corigliano S, Friguglietti C, Gauna A, Harach R, Munizaga F, Niepomniszcze H, Pitoia F, Pretell E, Vaisman M, Ward LS, Wohllk N, Tomimori E 2009 Latin American thyroid society recommendations for the management of thyroid nodules. Arq Bras Endocrinol Metabol 53:1167-1175.
7. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Pacini F, Schlumberger M, Sherman SI, Steward DL, Tuttle RM 2009 Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19:1167-1214.
8. Eszlinger M, Hegedus L, Paschke R 2014 Ruling in or ruling out thyroid malignancy by molecular diagnostics of thyroid nodules. Best Pract Res Clin Endocrinol Metab 28: 545-557.
9. Nikiforov YE, Nikiforova MN 2011 Molecular genetics and diagnosis of thyroid cancer. Nat Rev Endocrinol 7: 569-580.
10. Nikiforov YE, Ohori NP, Hodak SP, Carty SE, LeBeau SO, Ferris RL, Yip L, Seethala RR, Tublin ME, Stang MT, Coyne C, Johnson JT, Stewart AF, Nikiforova MN 2011 Impact of mutational testing on the diagnosis and management of patients with cytologically indeterminate thyroid nodules: a prospective analysis of 1056 FNA samples. J Clin Endocrinol Metab 96:3390-3397.
11. Nikiforov YE, Steward DL, Robinson-Smith TM, Haugen BR, Klopper JP, Zhu Z, Fagin JA, Falciglia M, Weber K, Nikiforova MN 2009 Molecular testing for mutations in improving the fine needle aspiration diagnosis of thyroid nodules. J Clin Endocrinol Metab 94:2092-2098.
12. Ohori NP, Nikiforova MN, Schoedel KE, LeBeau SO, Hodak SP, Seethala RR, Carty SE, Ogilvie JB, Yip L, Nikiforov YE 2010 Contribution of molecular testing to thyroid fine-needle aspiration cytology of "follicular lesion of undetermined significance/atypia of undetermined significance." Cancer Cytopathol 118:17-23.
13. Cantara S, Capezzone M, Marchisotta S, Capuano S, Busonero G, Toti P, Di SA, Caruso G, Carli AF, Brilli L, Montanaro A, Pacini F 2010 Impact of proto-oncogene mutation detection in cytological specimens from thyroid nodules improves the diagnostic accuracy of cytology. J Clin Endocrinol Metab 95:1365-1369.
14. Eszlinger M, Krogdahl A, Munz S, Rehfeld C, Precht Jensen EM, Ferraz C, Bosenberg E, Drieschner N, Scholz M, Hegedus L, Paschke R 2014 Impact of molecular screening for point mutations and rearrangements in routine air-dried fine-needle aspiration samples of thyroid nodules. Thyroid 24:305-313.
15. Baloch ZW, LiVolsi VA, Asa SL, Rosai J, Merino MJ, Randolph G, Vielh P, DeMay RM, Sidawy MK, Frable WJ 2008 Diagnostic terminology and morphologic criteria for cytologic diagnosis of thyroid lesions: a synopsis of the National Cancer Institute Thyroid Fine-Needle Aspiration State of the Science Conference. Diagn Cytopathol 36: 425-437.
16. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Sherman SI, Tuttle RM 2006 Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 16:109-142.
17. Ferraz C, Rehfeld C, Krogdahl A, Precht Jensen EM, Bosenberg E, Narz F, Hegedus L, Paschke R, Eszlinger M 2012 Detection of PAX8/PPARG and RET/PTC rearrangements is feasible in routine air-dried fine needle aspiration smears. Thyroid 22:1025-1030.
18. Rehfeld C, Munz S, Krogdahl A, Jensen EM, Siebolts U, Ferraz C, Bosenberg E, Hegedus L, Paschke R, Eszlinger M 2013 Impact of different methodologies on the detection of point mutations in routine air-dried fine needle aspiration (FNA) smears. Horm Metab Res 45:513-517.
19. Piana S, Frasoldati A, Ferrari M, Valcavi R, Froio E, Barbieri V, Pedroni C, Gardini G 2010 Is a five-category reporting scheme for thyroid fine needle aspiration cytology accurate? Experience of over 18, 000 FNAs reported at the same institution during 1998-2007. Cytopathology 22: 164-173.
20. Fadda G, Basolo F, Bondi A, Bussolati G, Crescenzi A, Nappi O, Nardi F, Papotti M, Taddei G, Palombini L 2010 Cytological classification of thyroid nodules. Proposal of the SIAPEC-IAP Italian Consensus Working Group. Pathologica 102:405-408.
21. Cibas ES, Baloch ZW, Fellegara G, LiVolsi VA, Raab SS, Rosai J, Diggans J, Friedman L, Kennedy GC, Kloos RT, Lanman RB, Mandel SJ, Sindy N, Steward DL, Zeiger MA, Haugen BR, Alexander EK 2013 A prospective assessment defining the limitations of thyroid nodule pathologic evaluation. Ann Intern Med 159:325-332.
22. DeLellis RA, Williams ED, LiVolsi V, Albores-Saavedra J, Baloch ZW, Wenig B, Cady B, Mazzaferri EL, Hay ID, Fagin JA, Weber AL, Caruso P, Voutilainen PE, Franssila KO, Schneider AB, Nikiforov YE, Rabes HM, Akslen LA, Ezzat S, Santoro M, Eng C, Harach HR, Sobrinho-Simoes M, Asa SL, Kroll TG, Farid P, Kitamura Y, Noguchi S, Ghossein RA, Lloyd RV, Chan JKC, Clark OH, Tallini G, Volante M, Pilotti S, Caracangiu P, Papotti M, Matias-Guiu X, Zakowski M, Sakamoto A, Ordonez N, Evans H, Haigh PI, Faquin W, Sugitani I, Giuffrida D, Boerner S, Hirokawa M, Osamura Y, Derwahl M, Paschke R, Belge G, Oriola J, Studer H 2004 Tumours of the Thyroid and Parathyroid. In: DeLellis RA, Lloyd RV, Heitz PU, Eng C (eds) WHO Classification of Tumours: Pathology & Genetics of Tumours of Endocrine Organs. IARC Press, Lyon, pp 51-103.
23. Ferraz C, Eszlinger M, Paschke R 2011 Current state and future perspective of molecular diagnosis of fine-needle aspiration biopsy of thyroid nodules. J Clin Endocrinol Metab 96:2016-2026.
24. Eszlinger M, Neustadt M, Ruschenburg I, Neumann A, Franzius C, Adam S, Bacher K, Hach A, Hammoser R, Langvogt C, Molwitz T, Paschke R 2014 [Fine-needle aspiration cytology of thyroid nodules: molecular diagnostics in a routine diagnostic setting]. Dtsch Med Wochenschr 139:476-480.
25. Fassina AS, Montesco MC, Ninfo V, Denti P, Masarotto G 1993 Histological evaluation of thyroid carcinomas: reproducibility of the "WHO" classification. Tumori 79: 314-320.
26. Franc B, de la Salmoniere P, Lange F, Hoang C, Louvel A, de Roquancourt A, Vilde F, Hejblum G, Chevret S, Chastang C 2003 Interobserver and intraobserver reproducibility in the histopathology of follicular thyroid carcinoma. Hum Pathol 34:1092-1100.
27. Lang W, Georgii A, Stauch G, Kienzle E 1980 The differentiation of atypical adenomas and encapsulated follicular carcinomas in the thyroid gland. Virchows Arch A Pathol Anat Histol 385:125-141.
28. Lloyd RV, Erickson LA, Casey MB, Lam KY, Lohse CM, Asa SL, Chan JK, DeLellis RA, Harach HR, Kakudo K, LiVolsi VA, Rosai J, Sebo TJ, Sobrinho-Simoes M, Wenig BM, Lae ME 2004 Observer variation in the diagnosis of follicular variant of papillary thyroid carcinoma. Am J Surg Pathol 28:1336-1340.
29. Ghossein R 2009 Update to the College of American Pathologists reporting on thyroid carcinomas. Head Neck Pathol 3:86-93.